FDA draft guidance on transdermal systems [BE/BA News]

posted by Ohlbe – France, 2023-04-13 10:37 (519 d 08:39 ago) – Posting: # 23523
Views: 1,508

Dear all,

If you're working on transdermal and topical delivery systems, you will be interested in two new FDA draft guidance documents:
- one on the assessment of irritation and sensitisation potential;
- one on the assessment of adhesion.
—
Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,224 posts in 4,878 threads, 1,654 registered users;
24 visitors (0 registered, 24 guests [including 7 identified bots]).
Forum time: 19:16 CEST (Europe/Vienna)

One of the symptoms of an approaching nervous breakdown
is the belief that one’s work is terribly important.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5